Search results for "Bowel disease"

showing 10 items of 449 documents

Anxiety, depression, chronic inflammation and aortic stiffness in Crohn's disease: the brain--gut--vascular axis.

2020

Background Patients with Crohn's disease have an increased aortic stiffness, a known cardiovascular risk factor. Anxiety, a key factor of the brain--gut axis in patients with Crohn's disease, is implicated in the pathogenesis and progression of the disease, and is linked with aortic stiffening in other clinical settings. Objectives Considering that depression is frequently linked to anxiety in Crohn's disease, we performed a mediation analysis to reveal the potential link between anxiety, depression and aortic stiffness in these patients. Methods Multicentre observational cross-sectional study of 86 consecutive patients with Crohn's disease and 86 matched control individuals. The connection…

medicine.medical_specialtyPhysiologypulse wave velocityDisease030204 cardiovascular system & hematologyAnxietyInflammatory bowel diseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineVascular StiffnessCrohn DiseaseInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineRisk factorPulse wave velocityDepression (differential diagnoses)Aortaarterial stiffness inflammation inflammatory bowel disease pulse wave velocityInflammationCrohn's diseasebusiness.industryDepressionPulse wave velocity.medicine.diseaseGastrointestinal MicrobiomeArterial stiffnearterial stiffnessCross-Sectional StudiesArterial stiffnessCardiologyAnxietymedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of hypertension
researchProduct

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

2020

The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohort, from a multicenter cohort from 21st of February to 30th of June, 2020. Ninety-seven patients with IBD (43 UC, 53 CD, one unclassified IBD) and concomitant COVID-19 over a total of 23,879 patients with IBD were enrolled in the study. The cumulative incidence of SARS-CoV-2 infection in patients with IBD vs. the general population was 0.406% and 0.402% cases, respectively. Twenty-three patients (…

medicine.medical_specialtyPopulationlcsh:MedicineInflammatory bowel diseaseArticledrugslaw.invention03 medical and health sciences0302 clinical medicinelawinflammatory bowel diseaseInternal medicinemedicineCumulative incidenceeducationeducation.field_of_studyimmunosuppressionbusiness.industryIncidence (epidemiology)lcsh:RCOVID-19General Medicinemedicine.diseaseIntensive care unitdigestive system diseasesPneumonia030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologybusinessCohort studyJournal of Clinical Medicine
researchProduct

ENTERAL NUTRITION SUPPORT TO TREAT MALNUTRITION IN INFLAMMATORY BOWEL DISEASE

2015

Malnutrition is a common consequence of inflammatory bowel disease (IBD). Diet has an important role in the management of IBD, as it prevents and corrects malnutrition. It is well known that diet may be implicated in the aethiology of IBD and that it plays a central role in the pathogenesis of gastrointestinal tract disease. Often oral nutrition alone is not sufficient in the pathogenesis of gastrointestinal tract disease. Often oral nutrition alone is not sufficient in the management of IBD patients, especially in children or elederly, and must be combined with oral supplementation or replaced with tube enteral nutrition. In this review, we describe several different approaches to enteral …

medicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaInflammatory Bowel Diseases IBD enteral feeding mulnutrition dysbiosis dismicrobism home enteral nutritionNutritional Statuslcsh:TX341-641ReviewDiseaseClinical nutritionInflammatory bowel diseaseEnteral administrationEnteral Nutritioninflammatory bowel diseasemedicineHumansDisease management (health)tube feedingIntensive care medicineSettore MED/12 - GastroenterologiaNutrition and Dieteticsbusiness.industryMalnutritionDisease ManagementInflammatory Bowel Diseasesmedicine.diseasedigestive system diseasesMalnutritionSettore MED/18 - Chirurgia GeneraleParenteral nutritionhome enteral nutritionEtiologyenteral feedingnutrients supplementationbusinesslcsh:Nutrition. Foods and food supplyFood Science
researchProduct

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

2014

Many placebo controlled trials and meta-analyses evaluated the efficacy of different drugs for the treatment of inflammatory bowel disease (IBD), including immunosuppressants and biologics. Their use is indicated in moderate to severe disease in non responders to corticosteroids and in steroid-dependent patients, as induction and maintainance treatment. Infliximab, as well as cyclosporine, is considered a second line therapy in the case of severe ulcerative colitis, or non-responders to intravenous corticosteroids. An adequate dosage and duration of therapy with thiopurines should be reached before evaluating their efficacy. Methotrexate is a valid option in patients with Crohn’s disease bu…

medicine.medical_specialtySettore MED/09 - Medicina InternaCombination therapyInflammatory bowel diseaseGastroenterologyimmunosuppresantbiologicsinflammatory bowel diseaseCrohn DiseaseGastrointestinal AgentsRisk FactorsInternal medicinemedicineimmunomodulators.optimization. treatmentHumansTopic HighlightBiological ProductsGastrointestinal agentCrohn's diseaseThiopurine methyltransferasebiologybusiness.industryGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisTacrolimusInfliximabSurgeryTreatment Outcomebiology.proteinColitis UlcerativeDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drug
researchProduct

The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature.

2012

Inflammatory bowel diseases are associated with an increased risk of vascular complications. The most important are arterial and venous thromboembolisms, which are considered as specific extraintestinal manifestations of inflammatory bowel diseases. Among venous thromboembolism events, portal vein thrombosis has been described in inflammatory bowel diseases. We report three cases of portal vein thrombosis occurring in patients with active inflammatory bowel disease. In two of them, hepatic abscess was present. Furthermore, we performed a systematic review based on the clinical literature published on this topic.

medicine.medical_specialtySettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyClinical courseInflammatory Bowel DiseasesReview ArticleClinical literaturemedicine.diseaseGastroenterologyInflammatory bowel diseasePortal vein thrombosisIncreased riskInternal medicineportal thrombosis.inflammatory bowel diseaseMedicineIn patientlcsh:Diseases of the digestive system. Gastroenterologylcsh:RC799-869businessVenous thromboembolism
researchProduct

Methodology for high-quality studies on course and prognosis of inflammatory bowel disease.

2012

Inflammatory bowel diseases (IBDs) are characterized by a chronic course with an alternation of relapses and remissions. Questions about prognosis are important for the patient who wants to know how the disease will affect his/her life and also for clinicians to make management decisions. Correct selection of the patients is the basis for good methodological studies on the course of IBD. A great proportion of data on the course of IBD is derived from a limited number of cohort studies. Studies help to define the endpoints for clinical trials and to identify subsets of patients in whom the prognosis of the disease can be stratified according to clinical features. Specific scientific requirem…

medicine.medical_specialtySettore MED/09 - Medicina InternaReferralmedia_common.quotation_subjectPopulationDiseaseInflammatory bowel diseaseCohort StudiesRisk FactorsNeoplasmsOutcome Assessment Health CareMedicineHumansProspective StudiesTopic HighlighteducationProspective cohort studyIntensive care medicineReferral and ConsultationMETHODOLOGY.COURSE OF DISEASE.INFLAMMATORY BOWEL DISEASEmedia_commonSelection biaseducation.field_of_studybusiness.industryGastroenterologyGeneral Medicinemedicine.diseaseInflammatory Bowel DiseasesPrognosisClinical trialResearch DesignPhysical therapybusinessCohort studyWorld journal of gastroenterology
researchProduct

BENEFICIAL EFFECT OF PROBIOTICS ADMINISTRATION IN INFLAMMATORY BOWEL DISEASE AND RELATED SPONDYLOARTHROPATHY: A PROSPECTIVE STUDY

2015

Background: Therapeutic treatment for inflammatory bowel disease (IBD) may follow different approaches, systemic as well as local, especially when the target is the osteoarticular apparatus. Although some clinical trials have suggested benefits from probiotics administration in IBD, there is still a great deal of controversy on their use. The aim of this study was to further investigate the effects of probiotics in patients with IBD and related spondyloarthropathy. Material/Methods: Fifty-nine patients affected by IBD with extra-intestinal involvement where evaluated from 2006 to 2010. Twenty-eight patients received administration of a standard therapy with mesalazine and 31 where treated w…

medicine.medical_specialtySettore MED/09 - Medicina InternaSpondyloarthropathyBiomedical EngineeringBioengineeringInflammatory bowel diseaseGastroenterologylaw.inventionchemistry.chemical_compoundProbioticMesalazineRandomized controlled triallawInternal medicinemedicineIn patientProspective cohort studyGeneral PsychologyInflammatory Bowel Disease IBD Microbiome Dysbiosis MALTbusiness.industrySettore BIO/16 - Anatomia UmanaGeneral Medicinemedicine.diseaseClinical trialSettore MED/18 - Chirurgia Generalechemistrybusiness
researchProduct

Inflammation and Aortic Stiffness: An Individual Participant Data Meta‐Analysis in Patients With Inflammatory Bowel Disease

2017

Background The recent finding that aortic pulse wave velocity ( aPWV ) is increased in patients with inflammatory bowel disease may explain why the cardiovascular risk is increased despite the low prevalence of traditional cardiovascular risk factors. We aimed to test whether inflammation is associated with aortic stiffening in this setting after adjustment for major confounders and to perform subgroup analyses. Methods and Results A systematic literature search for aPWV in inflammatory bowel disease was performed using PubMed, Scopus, Web of Science, and Google Scholar databases (last accessed May 7, 2017). Inclusion criterion was peer‐reviewed publications on clinical studies reporting o…

medicine.medical_specialtySettore MED/09 - Medicina Internapulse wave velocitycardiovascular complicationsBlood SedimentationPulse Wave Analysis030204 cardiovascular system & hematologyStandard scoreInflammatory bowel diseaseLeukocyte Count03 medical and health sciencesVascular Stiffness0302 clinical medicineCrohn DiseaseRisk FactorsInternal medicinemedicineHumansArterial stiffness; Cardiovascular complications; Crohn's disease; Inflammation; Pulse wave velocity; Ulcerative colitis; Cardiology and Cardiovascular Medicine030212 general & internal medicineulcerative colitisInflammationSystematic Review and Meta‐AnalysisCrohn's diseasemedicine.diagnostic_testbusiness.industryMeta Analysisinflammation aortic stiffnessPrognosismedicine.diseaseUlcerative colitisConfidence intervalCrohn's diseaseC-Reactive Proteinarterial stiffnessCardiovascular DiseasesMeta-analysisErythrocyte sedimentation rateMultivariate AnalysisHypertensionLinear ModelsPhysical therapyArterial stiffnessColitis UlcerativeInflammation MediatorsCardiology and Cardiovascular MedicinebusinessBiomarkersJournal of the American Heart Association
researchProduct

Responses to self and non-self intestinal microflora in health and inflammatory bowel disease.

1997

medicine.medical_specialtyT-LymphocytesImmunologyBiologyCross ReactionsInflammatory bowel diseaseGastroenterologyAntibodiesImmune tolerancePathogenesisMiceImmune systemCrohn DiseaseInternal medicinemedicineAnimalsHumansCrohn diseaseCross reactionsmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisInterleukin-12Interleukin-10IntestinesInterleukin 10Disease Models AnimalImmunologyForecastingResearch in immunology
researchProduct

A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial

2018

Background: Telemedicine has been successfully used to provide inflammatory bowel disease (IBD) patients with health care services remotely via the implementation of information and communications technology, which uses safe and feasible apps that have been well accepted by patients in remission. However, the design of telemedicine apps in this setting involves difficulties that hinder the adherence of patients to the follow-up plans and the efficacy of these systems to improve disease activity and quality of life. Objective: This study aimed to evaluate the development of a Web platform, Telemonitoring of Crohn Disease and Ulcerative Colitis (TECCU), for remote monitoring of patients with …

medicine.medical_specialtyTelemedicine020205 medical informatics02 engineering and technologyInflammatory bowel diseaselaw.invention03 medical and health sciences0302 clinical medicineQuality of life (healthcare)information technologyRandomized controlled trialinflammatory bowel diseaselawHealth careProtocol0202 electrical engineering electronic engineering information engineeringmedicineeHealthDisease management (health)Intensive care medicineulcerative colitisbusiness.industryCrohn diseaseGeneral Medicinemedicine.diseaseClinical trialeHealth030211 gastroenterology & hepatologytelemedicinebusinessJMIR Research Protocols
researchProduct